Pakistan, one of the first countries in the world to allow private imports of the COVID-19 vaccine. Before that has received a number of Russian Sputnik vaccine for commercial sale. Now from this week, a private company in Pakistan will begin taking deliveries of the China CanSino Biologics COVID-19 vaccine for commercial sale, a spokesman for the company’s local partners said Monday.
Abbas said the trade name for the vaccine was “Convidecia”. Five hospitals involved in clinical trials for the vaccine will receive commercial doses, in addition, he said.
“We expect the first 10,000 doses to come on March 25, and 100,000 next month and 200,000 the month after,” said Hassan Abbas, an employee of AJ Pharma, CanSino’s local partner, which will import the vaccine.
Pakistan is in the process of vaccinating healthcare workers and citizens over 60 with a free dose of Sinopharm donated from China.
The commercial administration of vaccines was postponed as the government resolved pricing issues. For the private sector after overturning its decision to allow unlimited pricing.
According to sources, the Russian Sputnik V vaccine costs 8,449 rupees for two doses. And the Chinese CanSino Biologics vaccine is 4,225 rupees per stroke.
In short, the cabinet agreed on the selling price of the two coronavirus vaccines.
Russian vaccine importers objected to the retail price, after which the government decided to reconsider it.
Pakistan is in the midst of a spike in COVID-19 infections, reporting the highest number of positive cases since last July on Saturday. Moreover Currently, 3,669 new cases and 20 new deaths reported.